Convelo Therapeutics, Inc

Convelo Therapeutics, Inc

Biotechnology Research Cleveland, Ohio, United States 8 employees
Employees
8
Contacts
2
Emails
2

Convelo Therapeutics, Inc Overview

Headquarters
Cleveland, Ohio, United States
Phone Number
Available in AeroLeads
Website
convelotx.com
Industry
Biotechnology Research
Employees
8
Founded
2016
Funding
10.8M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Convelo Therapeutics, Inc

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.

Convelo Therapeutics, Inc Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Convelo Therapeutics, Inc Org Chart

Sample employees and titles
Name Title Contact
Samantha Stubblefield, Phd Dedicated Drug Discovery Scientist
Email
Brad Lang Biotech Strategist & Builder - Seeking
View
Derrick Rossi Co-founder Moderna, Intellia
View
Drew Adams Academic Chemical Biologist
Email

Employees by Management Level

Individual contributor 5 profiles
Senior / Lead 2 profiles
Executive 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
IT 1 1 1
General 1 1 1
Executive 1 1 1

Convelo Therapeutics, Inc Tech Stack

Data / AI 4 profiles
Engineering 1 profile

Compare Similar Companies to Convelo Therapeutics, Inc